More specifically, a series of genes (namely, ATG5, ATG12, ATG16L1, PI3KC3, AMBRA1, and UVRAG) showed similar expression patterns across different MDS patients, alluding to regulation by the same factors. This evidence concerns the gene ATG5 and myelodysplastic syndrome.